The current ARFXF market cap is 7.14M. The company's latest EPS is USD -0.1887 and P/E is -0.53.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1,000 | 2k | 0 | 0 | 0 |
Operating Income | -7.36M | -5.68M | -8.29M | -23.38M | -14.26M |
Net Income | -7.4M | -5.66M | -9.79M | -18.06M | -13.21M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.07M | 1.39M | 17.75M | 6.93M | 13.62M |
Total Liabilities | 1.68M | 2.4M | 12.09M | 8.27M | 9.87M |
Total Equity | 398k | -1.02M | 5.66M | -1.35M | 3.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.09M | -4.36M | -9.31M | -17.03M | -10.84M |
Investing | N/A | -112k | 95k | -2k | -1,000 |
Financing | 5.36M | 3.83M | 25.52M | 6.49M | 17.75M |
Market Cap | 7.14M |
Price to Earnings Ratio | -0.53 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.56 |
Price to Book Ratio | 1.87 |
Dividend Yield | - |
Shares Outstanding | 70M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (9.35%) |
Company Name | Promis Neurosciences Inc (QB) |
Address |
suite 200 toronto, ontario M4S 3E2 |
Website | https://www.promisneurosciences.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.